middle.news
Galidesivir Secures FDA Orphan Drug Status for Marburg Virus Treatment
8:54am on Wednesday 17th of June, 2026 AEST
•
Pharmaceuticals
Read Story
Galidesivir Secures FDA Orphan Drug Status for Marburg Virus Treatment
8:54am on Wednesday 17th of June, 2026 AEST
Key Points
FDA grants Orphan Drug Designation for Galidesivir
Seven years of US market exclusivity potential
Supports upcoming dose optimisation studies
Strengthens biodefence and outbreak preparedness role
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE